Juvabis AG is a clinical stage biotech company developing the next generation of aminoglycoside antibiotics. Its first-in-class human therapeutic portfolio demonstrates preclinical safety and efficacy in critical systemic infections by highly drug-resistant Gram-negative pathogens and mycobacteria.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business